Nav: Home

Renowned researchers present at ASN Scientific Sessions to advance the science of stevia

April 20, 2017

CHICAGO, IL, April 19, 2017 - To examine the latest scientific evidence related to non-caloric sweeteners, focused on stevia, the Global Stevia Institute is hosting a sponsored symposium on Saturday, April 22 from Noon - 3:00 PM at the American Society for Nutrition (ASN) Scientific Sessions, taking place at the annual Experimental Biology conference in Chicago.

"The symposium features leading researchers from around the globe who will present the latest scientific evidence related to the health benefits, safety and innovations in low/zero calorie sweeteners, with a focus on the newest natural-origin sweetener, stevia," said symposium chair and Global Stevia Institute director, Dr. Priscilla Samuel.

Stevia is plant based, zero calorie, and sustainable sweetening ingredient for foods and beverages. It is a new kind of sweetener because stevia is neither like sugar - as it has no calories - nor an artificial sweetener, as it is a natural plant extract, making it ideal for people who want zero calorie sweetness from a natural source.

Stevia Leaf to Stevia Sweetener: Exploring its Science, Benefits & Future Potential

The symposium is open to all registered attendees of the Experimental Biology conference. Featured speakers and topics include:

Keith Ayoob, EdD, RD, FADA of Albert Einstein College of Medicine, Bronx, NY and co-chair of the symposium, provides a historical perspective on the development of stevia as a sweetener.
  • The stevia plant was discovered more than 200 years ago in South America
  • Japan was the first to commercialize stevia in 1971. High-purity stevia leaf extract received U.S. GRAS status in in 2008, followed by approvals by Codex Alimentarius and the European Commission. To date, all major global regulatory organizations have approved the use of high purity stevia leaf extracts in food and beverages.

Ursula Wölwer-Rieck, PhD, of the University of Bonn, Germany highlights the naturality of stevia leaf extract and emerging innovations.
  • Findings from a recent study showed that steviol glycosides are not altered during the extraction and purification process, providing evidence for the naturality of high purity stevia leaf extract sweeteners.
  • Discussion of new innovations being explored for steviol glycosides from the stevia leaf and other sources.

Berna Magnuson, PhD, of Health Science Consultants, Canada, reviews the metabolic fate and safety of stevia leaf extract.
  • All steviol glycosides follow a similar metabolic pathway, demonstrating that toxicology studies conducted on one glycoside are relevant to the safety assessment of others.
  • Regulatory authorities around the globe have determined consumption of high-purity stevia leaf extract at or below the ADI, is safe for all, including children, pregnant women and people with diabetes.

Per Bendix Jeppesen, PhD, University of Aarhus, Denmark delves into stevia's impact on blood glucose, diabetes and overall health.
  • Reviews research on the beneficial health effects of steviol glycosides versus other sweeteners and their effect on blood glucose and insulin resistance particularly in type-2 diabetics.

Peter Rogers, PhD, University of Bristol, UK addresses the debate of whether low/no-calorie sweeteners help or hurt appetite and weight management.
  • Reviews intervention studies that show consuming low/no-calorie sweeteners (LNCS) help reduce energy intake and body weight, and examines recent evidence that contradicts claims that consumption of LNCS increase desire for sweetness, and disrupt appetite control by confusing the relationship between sweet taste and calories.

Ian Rowland, PhD, University of Reading, UK looks at the influence of low/no-calorie sweeteners on gut microbiota and interactions.
  • Discusses the effect of low/no calorie sweeteners (LNCS) on the gut microbiome. While most LNCS are not metabolized by gut bacteria, steviol glycosides (such as rebaudioside A and stevioside) are a notable exception. The effects of the gut microbiota on stevia and vice versa are discussed.

The symposium concludes with a summary and consumer and stevia market insights by chair and Global Stevia Institute director, Priscilla Samuel, Ph.D.
  • Consumer demand for a zero- calorie sweetener from a natural source continues to drive the growth of stevia. Since 2008, more than 12,000 products have launched with stevia. In 2016 alone, close to 3,000 products launched globally with stevia.
  • PureCircle proprietary research shows that 70% of U.S. consumers are aware of stevia as a sweetener, a significant increase from the 40% aided awareness levels in 2010. Consumers also recognize that stevia is a naturally-sourced ingredient from the stevia plant.

About the Global Stevia Institute

The Global Stevia Institute (GSI) provides science-based information about stevia, a plant-based, zero calorie sustainable sweetener of natural origin. The GSI was founded in June 2010, to advance and share scientific research and provide education on stevia for health professionals, scientists, public affairs leaders, consumers and food and beverage manufacturers internationally. GSI is advised by an international board of leading scientists and health professionals. GSI is supported by PureCircle, Ltd., a global leader in purified stevia leaf extract ingredients. For more information, and to sign up to be part of the Stevia Community, visit


Related Blood Glucose Articles:

Loss of gland in eyelids may be a biomarker for elevated blood glucose in diabetes
In patients with diabetes, loss of the gland that helps lubricate the eye may be a sign of elevated blood glucose levels, according to research accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting.
Medtronic MiniMed 670G insulin pump allows 'excellent' blood glucose control
Patients with type 1 diabetes who use Medtronic's MiniMedTM 670G insulin pump system are able to maintain blood glucose levels in the targeted range over 71% of the time, according to a study that analyzed some 6 million days of real-world data.
'Revita' improves blood glucose levels, liver metabolic health in type 2 diabetes
Patients with poorly controlled type 2 diabetes who underwent a novel, minimally invasive, endoscopic procedure called Revita® duodenal mucosal resurfacing (DMR) had significantly improved blood glucose (sugar) levels, liver insulin sensitivity, and other metabolic measures three months later, according to new data from the REVITA-2 study.
Artificial pancreas system better controls blood glucose levels than current technology
Study based at the Icahn School of Medicine at Mount Sinai and other centers finds new system has safety, efficacy benefits for people with type 1 diabetes
New study sheds light on how blood vessel damage from high glucose concentrations unfolds
A mechanism in the cells that line our blood vessels that helps them to process glucose becomes uncontrolled in diabetes, and could be linked to the formation of blood clots and inflammation according to researchers from the University of Warwick.
Blood pressure and glucose control may prevent common arrhythmia
Blood-pressure and glucose control may be effective in preventing heart block, a common form of arrhythmia, and the subsequent need for a pacemaker, according to a study by researchers at UC San Francisco.
Time-restricted eating shows benefits for blood glucose
By restricting the time period during which they could eat, researchers have seen promising results for controlling blood glucose levels in men at risk of type 2 diabetes.
Leaving 2-hour gap between dinner and bedtime may not affect blood glucose
Leaving a two-hour gap between the last meal of the day and bedtime doesn't seem to be associated with any discernible difference in blood glucose levels among healthy adults over the long term, suggests Japanese research published in the online journal BMJ Nutrition, Prevention & Health.
UMN medical school researchers study abnormal blood glucose levels of discharged patients
University of Minnesota Medical School researchers decided to delve into an area where little data currently exists.
Nutrients may reduce blood glucose levels
One amino acid, alanine, may produce a short-term lowering of glucose levels by altering energy metabolism in the cell.
More Blood Glucose News and Blood Glucose Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at